Low C1-inhibitor levels predict early restenosis after eversion carotid endarterectomy

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 27, Issue 12, 2007, Pages 2756-2762

  Széplaki, Gábor ^a   Varga, Lilian ^a   Laki, Judit ^a   Dósa, Edit ^b   Rugonfalvi Kiss, Szabolcs ^a   Madsen, Hans O ^c   Prohászka, Zoltán ^a,d   Kocsis, Andrea ^d   Gál, Péter ^d   Szabó, Attila ^b   Acsády, György ^b   Karádi, István ^a,d   Selmeci, László ^b   Garred, Peter ^c   Füst, George ^a,b,d   Entz, László ^b  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c Rigshospitalet   (Denmark)

^d INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Carotid arteries; Genetics; Inflammation; Restenosis; Risk factors

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; MANNOSE BINDING LECTIN 2;

ADULT; AGED; ARTICLE; CAROTID ENDARTERECTOMY; CAROTID RESTENOSIS; CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; INTERNAL CAROTID ARTERY STENOSIS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREDICTION AND FORECASTING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESTENOSIS; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE;

ADULT; AGED; BIOLOGICAL MARKERS; CAROTID STENOSIS; COMPLEMENT C1 INACTIVATOR PROTEINS; DOWN-REGULATION; ENDARTERECTOMY, CAROTID; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MANNOSE-BINDING LECTIN; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; SERPINS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 36348991407     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.107.146860     Document Type: Article

References (34)

1. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1991;325:445-453.
2. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 1995;273:1421-1428.
3. Trisal V, Paulson T, Hans SS, Mittal V. Carotid artery restenosis: an ongoing disease process. Am Surg. 68:275-279, 2002; discussion 279-280.
4. Frericks H, Kievit J, van Baalen JM, van Bockel JH. Carotid recurrent stenosis and risk of ipsilateral stroke: a systematic review of the literature. Stroke. 1998;29:244-250.
5. Moore WS, Kempczinski RF, Nelson JJ, Toole JF. Recurrent carotid stenosis: results of the asymptomatic carotid atherosclerosis study. Stroke. 1998;29:2018-2025.
6. Ganesan R, Cote R, Mackey A. Significance of carotid restenosis following endarterectomy. Cerebrovasc Dis. 1998;8:338-344.
7. Ladowski JS, Shinabery LM, Peterson D, Peterson AC, Deschner WP. Factors contributing to recurrent carotid disease following carotid endarterectomy. Am J Surg. 1997;174:118-120.
8. Reina-Gutierrez T, Serrano-Hernando FJ, Sanchez-Hervas L, Ponce A, Vega de Ceniga M, Martin A. Recurrent carotid artery stenosis following endarterectomy: natural history and risk factors. Eur J Vasc Endovasc Surg. 2005;29:334-341.
9. Rugonfalvi-Kiss S, Dósa E, Madsen HO, Endrész V, Prohászka Z, Laki J, Karádi I, Gönczöl E, Selmeci L, Romics L, Füst G, Entz L, Garred P. High rate of early restenosis after carotid eversion endarterectomy in homozygous carriers of the normal mannose-binding lectin genotype. Stroke. 2005;36:944-948.
10. Széplaki G, Varga L, Laki J, Dósa E, Madsen HO, Prohászka Z, Szabó A, Acsády G, Selmeci L, Garred P, Füst G, Entz L. Elevated complement C3 is associated with early restenosis after eversion carotid endarterectomy. Thromb Haemost. 2006;96:529-534.
11. Madsen HO, Videm V, Svejgaard A, Svennevig JL, Garred P. Association of mannose-binding-lectin deficiency with severe atherosclerosis. Lancet. 1998;352:959-960.
12. Thiel S, Vorup-Jensen T, Stover CM, Schwaeble W, Laursen SB, Poulsen K, Willis AC, Eggleton P, Hansen S, Holmskov U, Reid KB, Jensenius JC. A second serine protease associated with mannan-binding lectin that activates complement. Nature. 1997;386:506-510.
13. Walport MJ. Complement. First of two parts. N Engl J Med. 2001;344:1058-1066.
14. Caliezi C, Wuillemin WA, Zeerleder S, Redondo M, Eisele B, Hack CE. C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Pharmacol Rev. 2000;52:91-112.
15. Kostner KM, Fahti RB, Case C, Hobson P, Tate J, Marwick TH. Inflammation, complement activation and endothelial function in stable and unstable coronary artery disease. Clin Chim Acta. 2006;365:129-134.
16. Dósa E, Rugonfalvi-Kiss S, Prohászka Z, Szabó A, Karadi I, Selmeci L, Romics L, Füst G, Acsády G, Entz L. Marked decrease in the levels of two inflammatory markers, hs-C-reactive protein and fibrinogen in patients with severe carotid atherosclerosis after eversion carotid endarterectomy. Inflamm Res. 2004;53:631-635.
17. Entz L, Járányi S, Nemes A. Eversion endarterectomy in surgery of the internal carotid artery. Cardiovasc Surg. 1996;4:190-194.
18. Biller J, Feinberg WM, Castaldo JE, Whittemore AD, Harbaugh RE, Dempsey RJ, Caplan LR, Kresowik TF, Matchar DB, Toole JF, Easton JD, Adams HP Jr, Brass LM, Hobson RW, 2nd, Brott TG, Sternau L. Guidelines for carotid endarterectomy: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation. 1998;97:501-509.
19. Kohler PF, Muller-Eberhard HJ. Immunochemical quantitation of the third, fourth and fifth components of human complement: concentrations in the serum of healthy adults. J Immunol. 1967;99:1211-1216.
20. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
21. Garred P, J JS, Quist L, Taaning E, Madsen HO. Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J Infect Dis. 2003;188:1394-1403.
22. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448-454.
23. Zahedin R, Davis AE. C1-inhibitor. In: Morley BJ, Walport MJ, eds. The Complement FactsBook. London: Academic Press; 2000.
24. Yasuda M, Kawarabayashi T, Akioka K, Teragaki M, Oku H, Kanayama Y, Takeuchi K, Takeda T, Kawase Y, Ikuno Y. The complement system in the acute phase of myocardial infarction. Jpn Circ J. 1989;53:1017-1022.
25. Jordan JE, Montalto MC, Stahl GL. Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury. Circulation. 2001;104:1413-1418.
26. Collard CD, Vakeva A, Morrissey MA, Agah A, Rollins SA, Reenstra WR, Buras JA, Meri S, Stahl GL. Complement activation after oxidative stress: role of the lectin complement pathway. Am J Pathol. 2000;156:1549-1556.
27. Collard CD, Montalto MC, Reenstra WR, Buras JA, Stahl GL. Endothelial oxidative stress activates the lectin complement pathway: role of cytokeratin 1. Am J Pathol. 2001;159:1045-1054.
28. Lin ZH, Fukuda N, Jin XQ, Yao EH, Ueno T, Endo M, Saito S, Matsumoto K, Mugishima H. Complement 3 is involved in the synthetic phenotype and exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension. 2004;44:42-47.
29. Szabó A, Laki J, Madsen HO, Dósa E, Prohászka Z, Rugonfalvi-Kiss S, Kókai M, Acsádi G, Karádi I, Entz L, Selmeci L, Romics L, Füst G, Garred P, Cervenak L. Early rise in serum VEGF and PDGF levels predisposes patients with a normal MBL2 genotype to restenosis after eversion endarterectomy. Stroke. 2007;38:2247-2253.
30. de Zwaan C, Kleine AH, Diris JH, Glatz JF, Wellens HJ, Strengers PF, Tissing M, Hack CE, van Dieijen-Visser MP, Hermens WT. Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarction. Eur Heart J. 2002;23:1670-1677.
31. Thielmann M, Marggraf G, Neuhauser M, Forkel J, Herold U, Kamler M, Massoudy P, Jakob H. Administration of C1-esterase inhibitor during emergency coronary artery bypass surgery in acute ST-elevation myocardial infarction. Eur J Cardiothorac Surg. 2006;30:285-293.
32. Muscari A, Massarelli G, Bastagli L, Poggiopollini G, Tomassetti V, Volta U, Puddu GM, Puddu P. Relationship between serum C3 levels and traditional risk factors for myocardial infarction. Acta Cardiol. 1998;53:345-354.
33. Ajjan R, Grant PJ, Futers TS, Brown JM, Cymbalista CM, Boothby M, Carter AM. Complement C3 and C-reactive protein levels in patients with stable coronary artery disease. Thromb Haemost. 2005;94:1048-1053.
34. Széplaki G, Prohászka Z, Duba J, Rugonfalvi-Kiss S, Karádi I, Kókai M, Kramer J, Füst G, Kleiber M, Romics L, Varga L. Association of high serum concentration of the third component of complement (C3) with pre-existing severe coronary artery disease and new vascular events in women. Atherosclerosis. 2004;177:383-389.